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Background: The Beck Depression Inventory-II (BDI-II), the Inventory of Depressive Symptoms (self-
report) (IDS-SR) and the Montgomery-Äsberg Depression Rating Scale (MADRS) are questionnaires that
assess symptom severity in patients with a depressive disorder, often part of Routine Outcome
Monitoring (ROM). We aimed to generate reference values for both “healthy” and “clinically depressed”
populations.
Methods: We included 1295 subjects from the general population (ROM reference-group) recruited
through general practitioners, and 4627 psychiatric outpatients diagnosed with Major Depressive
Disorder (MDD) or dysthymia (ROM patient-group). The outermost 5% of observations were used to
deﬁne limits for one-sided reference intervals (95th percentiles; P95). Receiver Operating Characteristics
(ROC) analyses were used to yield alternative cut-off values. Internal consistency was assessed.
Results: The mean age was 40.3 yr (SD¼12.6) and 39.3 (SD¼12.3) for the ROM reference and patient-
groups, respectively, and 62.8% versus 61.0% were female. Cut-off (P95) values differed for women and
men, being respectively 15 and 12 for the BDI-II, 23 and 18 for the IDS-SR, and 12.5 and 9 for the MADRS.
ROC analyses yielded almost equal reference values. The discriminative power of the BDI-II, IDS-SR and
MADRS scores was very high. Internal consistency was excellent for total scores and satisfactory for all
subscales, except for the IDS-SR subscale Atypical Characteristics.
Limitations: Substantial non-response and limited generalizability.
Conclusions: For the BDI-II, IDS-SR and MADRS a comprehensive set of reference values were provided.
Reference values were higher in women than in men, implying the use of sex-speciﬁc cut-off values.
Either instrument can be offered to every patient with MAS disorders to make responsible decisions
about continuing, changing or terminating therapy.
& 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Routine Outcome Monitoring (ROM) is the periodically repeated
assessment of the condition of patients using diagnostic instruments
and severity scales that may aid the evaluation of treatment. Both
generic and disorder-speciﬁc measurement instruments are used.
Generic instruments are completed by all patients and assess a broad
range of psychopathological symptoms irrespective of their psychiatric
disorder(s). Disorder-speciﬁc instruments are administered to patientsLeiden University Medical
etherlands.
c.nl,
aaren).
lsevier OA license.who meet the criteria for a particular disorder (De Beurs et al., 2011;
Schulte-van Maaren et al., 2013).
Reliable ratings from reference populations are essential to
correctly interpret ROM results for clinical decisions on continuing,
altering or terminating treatment (Kazdin, 2008). Furthermore,
they can facilitate referral from specialized mental health care
back to primary care. When establishing and interpreting refer-
ence values, several aspects need to be considered. First, reference
values (Solberg and Grasbeck, 1989) are often established in
healthy populations (Solberg, 2008) with health clearly deﬁned
(a priori) by inclusion and exclusion criteria (Geffre et al., 2009;
Katayev et al., 2010; Sasse et al., 2000). As a consequence “super-
normal” (i.e., too healthy) participants are selected (Kendall et al.,
1999) resulting in unreasonable (often 10% narrower) reference
intervals (Horn et al., 2001). Second, (sub)sample sizes of at least
120 are needed to reduce the amount of uncertainty and error
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tend toward a non-Gaussian distribution non-parametric percen-
tile scores (Reed et al., 1971; Solberg, 2008) are more appropriate
reference values than parametric mean (and standard deviation
(SD) of conﬁdence interval) values or weighted cut-off scores
calculated by the Jacobson & Truax method (Jacobson and Truax,
1991). In that case, the 95th percentile commonly serves as the
reference value (Solberg, 2008). Finally, Receiver Operating Char-
acteristics (ROC) analyses can provide cut-offs when both refer-
ence and patient data are available, reﬂecting the optimal trade-off
between sensitivity and speciﬁcity (Fan et al., 2006).
The self-report Beck Depression Inventory-II (BDI-II) (Beck
et al., 2002; Beck and Steer, 1987), the Inventory of Depressive
Symptoms-Self-Report (IDS-SR) (Nolen and Dingemans, 2004;
Rush et al., 1996) and the observer-rated Montgomery Äsberg
Depression Rating Scale (MADRS) (Montgomery and Asberg, 1979)
are three frequently used ROM instruments that assess symptom
severity of Major Depressive Disorder (MDD). The BDI-II, rather
than the IDS-SR and MADRS, is also used as a diagnostic screening
instrument for MDD (Nolen and Dingemans, 2004). Previous BDI-II
studies reported cut-off and reference values for MDD outpatients
(Beck et al., 1996b; Steer et al., 1999) and inpatients (Kumar et al.,
2002; Steer et al., 2000). A study in 376 undergraduates (17–29 yr
of age) and older adults (55–90 yr of age) (Segal et al., 2008a)
reported a mean of 8.6 (SD¼7.7). IDS-SR reference values were
reported for depressed outpatients (Biggs et al., 2000; Rush et al.,
1986; Rush et al., 1996; Trivedi et al. 2004) and inpatients
(Corruble et al. 1999). For 118 normal controls a cut-off value of
≥18 was reported (Rush et al., 1996) and a mean of 2.1 (SD¼2.2)
for 23 normal controls. Many studies have reported means with
SDs or cut-off values for the MADRS studies but were done with
outpatients with MDD (Bondolﬁ et al., 2010; Hawley et al., 2002;
Khan et al., 2002; Zimmerman et al., 2004b), inpatients with MDD
(Hawley et al., 2002; Müller et al., 2000,2003), stroke patients
(Sagen et al., 2009) and old age pensioners (Engedal et al., 2012).
When all studies in healthy controls (total n¼569) were reviewed
means with SDs and the optimal cut-off scores were reported
(Zimmerman et al., 2004a). However, because of the strongly
positively skewed distribution of these total scores in healthy
populations, the assumption of a normal distribution does not
seem to be satisﬁed in these studies. Therefore, reference values
should preferably be based on a distribution-free percentile or ROC
methodologies.
The aim of this study was to establish reference values,
including percentiles, ROC-based cut-off points next to the more
commonly reported means with SDs for the BDI-II, IDS-SR and
MADRS. A sample of 1295 subjects from the general population,
recruited through General Practitioners (GPs), was compared with
a sample of 4627 outpatients diagnosed with MDD or dysthymia
(with or without other psychiatric disorders). Particular aspects of
the current study were that next to a well-deﬁned psychiatric
patient-group, a healthy, but not necessarily symptom free,
reference-group was included, and that both sample sizes
were large.2. Methods
2.1. Participants
Our analyses of reference values were based on two study
samples: a ROM reference sample from the general population and
a ROM sample of psychiatric outpatients.
A total of 1295 participants (62.8% females; mean age¼40.3 yr;
SD¼12.6) 18–65 yr old were included in the ROM reference-group, as
part of the “Leiden Routine Outcome Monitoring Study” (Schulte-vanMaaren et al., 2013; Van Noorden et al., 2010). In order to recruit a
representative general population sample participants were randomly
selected from the registration systems of eight GPs in the Leiden
region. In the Netherlands, 99.9% of the general population is
registered with a GP (Poortvliet et al., 2005). Participants receiving
treatment for psychiatric disorders and/or dependence on alcohol or
drugs within six months prior to the assessment were excluded
because the group was aimed to be a psychiatrically healthy
reference-group. Further exclusion criteria were hearing impairment
or limited cognitive or language abilities (i.e., aphasia, severe dyslexia
or dementia; illiteracy or insufﬁcient mastery of the Dutch language).
To make the group demographically comparable to the ROM patient-
group the reference-group was matched for gender, age and
urbanization-level (62.3% urban). Participants in the reference-group
completed the same assessments as the patient-group, except that the
ROM reference-group completed every disorder-speciﬁc instrument.
The response rate was 37.1%, as detailed previously (Schulte-van
Maaren et al., 2013; Schulte-van Maaren et al., 2012). Invitations for
this study were sent to 4840 persons; 1283 could not be contacted
and 67 were not included because of time constraints. Of the
remaining 3490 potential participants, we could generate complete
datasets of 1295 individuals.
The ROM patient-group consisted of a baseline sample of 4627
psychiatric outpatients, aged between 18 and 65 years (61.0%
females; mean age¼39.3, SD¼12.3), diagnosed with and treated
for depressive disorders (MDD or dysthymia) in the Leiden Uni-
versity Medical Center (LUMC) Department of Psychiatry or the
Rivierduinen specialized mental healthcare centers. Baseline
assessment was part of the usual ROM procedure. On average,
80% of the referred patients with a tentative diagnosis of Mood-,
Anxiety- and/or Somatoform (MAS) disorder were assessed with
ROM in the study period (Van Noorden et al., 2010).
2.2. Procedures and instruments
Procedures of the web-based ROM program of the LUMC
Department of Psychiatry are described in detail elsewhere
(Carlier et al., 2012; Van Fenema et al., 2012; Van Noorden et al.,
2010). For our study, we used baseline ROM assessments that
comprised a standardized diagnostic interview (Dutch version of
the Mini-International Neuropsychiatric Interview Plus, version
5.00-R: MINI-Plus) (Sheehan et al., 1998; Van Vliet et al., 2000;
Van Vliet and De Beurs, 2007), collection of sociodemographic and
socioeconomic data, observer-rated scales, and self-report instru-
ments. The assessments were performed by trained research
nurses in the outpatient clinics. The BDI-II was completed by
455 reference subjects and 4019 patients. Halfway through the
study, the BDI-II was replaced by the IDS-SR. The IDS-SR was
completed by another group of 769 reference subjects and 474
patients. The MADRS was completed by the majority of both
groups: 1291 reference subjects and 4627 patients. The BDI-II
measures the severity of self-reported depression in adolescents
and adults according to Diagnostic and Statistical Manual of
Mental Disorders (DSM-IV) (American Psychiatric Association,
1994) criteria for diagnosing MDD (Beck et al., 1996a; Beck et al.,
2002 Dutch version). It was a substantially revised and upgraded
version of the original Beck Depression Inventory (BDI) (Beck and
Steer, 1987). The BDI-II is scored by summing the scores for each of
the 21 items. Each item is rated on a 4-point scale ranging from
0 to 3, with higher scores indicating higher levels of depression.
The total score can range from 0 to 63, where scores from 0 to 13
denote “Minimal” depression; total scores from 14 to 19 denote
“Mild” depression; total scores from 20 to 28 denote “Moderate”
depression; total scores from 29 to 63 denote “Severe” depression.
In the international literature, next to the total score, two (Steer
et al., 1999; Storch et al., 2004; Whisman et al., 2000), three (Beck
Y.W.M. Schulte-van Maaren et al. / Journal of Affective Disorders 149 (2013) 342–349344et al., 2002) or no (Segal et al., 2008b) subscales have been
identiﬁed; the Cognitive (from now on noted as Cognitive1) and
Somatic-Affective (from now on Somatic-Affective1) subscales are
most commonly used (Kumar et al., 2002; Steer et al., 1999). They
consist of 8 and 13 items and sum scores range from 0 to 24 and
from 0 to 39, respectively (Beck et al., 1996a). Alternatively, the
Cognitive (from now on noted as Cognitive2; 7 items; sum scores
range from 0 to 21), Affective (Affective2; 5 items; sum scores
range from 0 to 15) and Somatic (Somatic2; 9 items; sum scores
range from 0 to 27) subscales can be used (Beck et al., 2002).
The IDS-SR self-report instrument (Nolen and Dingemans 2004;
Rush et al., 1996 Dutch translation) is designed to measure overall
depressive symptom severity. The IDS-SR consists of 30 items: 23 of
which cover the diagnostic DSM-IV criteria for MDD (including its
atypical and melancholic subtypes). Seven items are not diagnostic
criteria but commonly associated symptoms for MDD (e.g. irritable
mood, anxious mood). The items are rated on a 4-point Likert scale,
with scores ranging from 0 (no symptomatology) to 3 (most severe).
The total (sum)score ranges from 0 to 84, because only decreased or
increased weight and appetite are scored (i.e. 28 of 30 items are
scored). Scores from 0 to 13 denote “Normal/no” depression; total
scores from 14 to 21 denote “Possible/mild” depression; total scores
from 22 to 30 denote “Moderate” depression; total scores from 31
to 38 denote “Severe” depression; and scores from 39 onward
denote “Very severe” depression (Rush et al., 2000). Frequently
used subscales are the 10-item Atypical Characteristics subscale
(Novick et al., 2005) and 11-item Melancholic Characteristics sub-
scale (van Reedt Dortland et al., 2010).
The MADRS (Montgomery and Asberg, 1979) is a clinician-rated
instrument assessing severity and range of depressive symptoms.
The 10 items were designed to be particularly sensitive to treat-
ment effects and overall change. They are relevant to the illness
and occur in the majority of cases although they do not cover all 9
DSM-IV MDD criteria. The items emphasize psychological symp-
toms (Heo et al., 2007). Items are rated on a 7-point Likert scale
anchored at 4 points (0: symptom is absent; 6: symptom is totally
dominant) and summed to yield a total score that ranges from 0 to
60. Scores from 0 to 8 denote “Normal/no” depression; total scores
from 9 to 18 denote “Possible/mild” depression; total scores from
19 to 26 denote “Moderate” depression; total scores from 27 to 34
denote “Severe” depression; and scores from 35 onward denote
“Very severe” depression (Müller et al., 2000).
The MINI-Plus (Sheehan et al., 1998; Van Vliet et al., 2000; Van
Vliet and De Beurs, 2007) was used to establish the presence of
Axis I diagnosis according to the DSM-IV. This standardized
diagnostic interview comprises 23 modules for mood, anxiety,
psychotic, somatoform and eating disorders.
2.3. Statistical analyses
Analyses were performed in the two groups separately, while
ROC and internal consistency analyses were done using data from
both groups combined. In both groups, subjects who had more
than 1 missing value per subscale were excluded. Sociodemo-
graphic and psychopathological variables were descriptively ana-
lyzed (percentages in the case of categorical variables, means and
SDs for the continuous variables). Cut-off scores indicating an
optimal discrimination threshold between “healthy” and “clini-
cally depressed” were obtained by ROC analyses. Sensitivity and
speciﬁcity were chosen to be equal, taking into account the trade-
off between the two (Fan et al., 2006). The discriminatory power of
the instrument (sub)scales was assessed with the associated areas
under the ROC curve (AUCs), where AUC's over 0.75 were con-
sidered clinical useful with 0.85 showing moderate discriminatory
power and 0.95 very high power (Barnabei et al., 2007). The 5th,
25th, 50th, 75th and 95th percentiles were calculated. Use of thecentral 95% of the distribution in a reference-group is commonly
used in case of non-Gaussian distributions (Geffre et al., 2009;
Solberg and Grasbeck, 1989), the remaining 5% categorized as
being “abnormal” (Campbell and Robinson, 1993). We chose the
top 5% of the reference-group (95th percentiles, P95) as being
“abnormal” because the lowest 2.5% (functioning “abnormally”
good) is not identiﬁable in general population samples: the BDI-II,
IDS-SR and MADRS merely assess the level of dysfunctionality and
not the level of “health” or normal functionality. Likewise, the
bottom 5% of the patient-group (5th percentiles, P5) can be
considered as indistinguishable from people in the normal range.
Furthermore, means and SDs were calculated. Reference values
were calculated for all participants combined, as well as for
4 strata: young women (aged 18–40 yr), older women (aged 41–
65 yr), young men (aged 18-40 yr), and older men (aged 41–65 yr).
The internal consistency of the instruments was tested using
Cronbach's alpha for the total and any subscales (with 40.70
indicating adequate internal consistency). For all analyses, SPSS
version 17.0 was used.3. Results
3.1. Sociodemographic and psychopathological characteristics
The sociodemographic and psychopathological characteristics
of the ROM reference-group and patient-group are shown in
Table 1.
Mean age (40.3 yr (SD¼12.6) versus 39.3 (SD¼12.3), p¼0.14) and
gender distribution (62.8% versus 61.0% females, p¼0.25) were
comparable between the ROM reference and patient-groups. Partici-
pants from the ROM reference-group were more often married than
those from the ROM patient-group (68.7% versus 43.5%, po0.001),
less often living alone (15.5% versus 22.0%, po0.001). The ROM
reference-group showed higher levels of education than the ROM
patient-group (77.2% versus 49.5% higher education, po0.001). Level
of education was deﬁned as lower for general basic education only, or
lower vocational education, and as higher for middle or higher
vocational education, college or university. Furthermore, work-
related disability and unemployment were less prevalent in the
ROM reference-group (17.9% versus 54.3%, po0.001). Fewer partici-
pants in the ROM reference-group were of ethnic origin (deﬁned as
self or both parents not being born in the Netherlands). Of the ROM
reference-group 1.3% had at least one depressive disorder, compared
to 100% of the subjects from the ROM patient-group (inclusion
criterion). Of the ROM reference-group 8.1% met criteria of another
psychiatric disorder on the MINI-Plus. There was a considerable
amount of psychopathological co-morbidity with MDD in the ROM
patient-group (53.5%).
3.2. Internal consistency
The internal consistencies of the instruments' total- and sub-
scales for all subjects combined are shown in Table 3. The total
scales of all three instruments showed excellent internal consis-
tencies. Except for the IDS-SR Atypical Characteristics subscale
(with a questionable alpha) none of the subscales had Cronbach's
alphas below the critical cut-off of 0.70, indicating adequate
internal consistency.
3.3. Reference values
3.3.1. Percentiles, means and SDs
Percentiles and other reference values of the BDI-II, IDS-SR and
MADRS (sub-)scales in the ROM reference and patient-groups are
shown in Table 2. In the reference-group, the distribution of each
Table 1
Sociodemographic and psychopathological characteristics of the ROM reference (n¼1295) and ROM patient (n¼4627) groups.
ROM reference-group (n¼1295) ROM patient-group (n¼4627)
Gender (%)
Male 482 (37.2) 1779 (38.4) (p¼0.41)
Female 813 (62.8) 2848 (61.6)
Age (mean. SD) in years 40.3 (12.6) 39.3 (12.3) (p¼0.12)
Male 41.2 (12.6) 41.2 (12.0) (p¼0.98)
Female 39.7 (12.6) 38.1 (12.3) (p¼0.001)
Marital status (%)a (po0.001)
Married/cohabitating 890 (68.7) 2027 (43.8)
Divorced/separated/widow 78 (6.0) 689 (14.9)
Single 327 (25.3) 1382 (39.9)
Housing situation (%)a (po0.001)
Living alone 201 (15.5) 995 (21.5)
Living with partner 902 (69.7) 2067 (44.7)
Living with family 192 (14.8) 1036 (22.4)
Educational status (%)a,d (po0.001)
Lower 295 (22.8) 1843 (39.8)
Higher 1000 (77.2) 2253 (48.7)
Employment status (%)a (po0.001)
Employed part-time 509 (39.3) 838 (18.1)
Employed full-time 554 (42.8) 803 (17.4)
Unemployed/retired 197 (15.2) 1189 (25.7)
Work-related disability (%) 35 (2.7) 1268 (27.4)
Ethnic background (%)a–b (po0.001)
Dutch 1150 (88.8) 3103 (67.1)
Other ethnicity 134 (10.3) 954 (20.6)
MINI diagnoses (%) (po0.001)
Currently None 1174 (90.7) 0c
Mood disorder (single) 7 (0.5) 2159 (46.7)
Mood disorder (with comorbidity) 10 (0.8) 2468 (53.3)
Other psychiatric disorder 104 (8.1) 0c
ROM: Routine Outcome Monitoring.
a No data from 70 (1.5%)–570 (12.3%) patients.
b No data from 11 reference subjects.
c Selection criterion.
d Lower education: general basic education only, or lower vocational education higher education: middle or higher vocational education, college or university.
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was also demonstrated by the substantial percentage of partici-
pants having the lowest possible scores.
Two sets of BDI-II subscales were analyzed, the internationally
most commonly used Cognitive1 and Somatic-Affective1 BDI-II
subscales (Steer et al., 1999), and the Cognitive2, Affective2 and
Somatic2 subscales (Beck et al., 2002). For the ROM reference
group, Table 2 shows the following P95 cut-off values for the BDI-II
total- and subscales: for the total score 13; for the Cognitive1
subscale 5; for the Somatic-Affective1 subscale 10; for the Cogni-
tive2 subscale 4; for the Affective2 subscale 3; and for the Somatic2
subscale 8. The mean BDI-II total score was 3.7 (SD¼4.7) for the
ROM reference group, indicating that the overall majority was not
depressed. For comparison, in the MDD patient group the mean
was 30.8 (SD¼10.5), indicating severe depression in the majority
of patients. The P5 value for the ROM patient group was 14. For the
IDS-SR total- and subscales the P95 cut-off values for the ROM
reference group were for the total score 20; for the Atypical
Characteristics subscale 11; and for the Melancholical Character-
istics subscale 10. The mean IDS-SR total score was 6.7 (SD¼6.9)
for the ROM reference group, compared to 38.1 (SD¼12.1) in the
MDD patient group. The P5 value for the ROM patient group was
18. For the MADRS, the P95 reference score was 11. The mean
MADRS score was 2.8 (SD¼3.8) for the ROM reference group,
contrasting with 23.4 (SD¼7.8) for the MDD patient group. The P5
value for the ROM patient group was 11.
Supplementary Tables 1 through 3 (see Appendix, available with
the full text of this article), show the reference values according togender- and age-strata. For the self-report BDI-II and IDS-SR higher age
was associated with a higher severity of MDD symptoms in women
and men from the ROM reference group, which was not the case for
the observer-rated MADRS. Women from the ROM reference group
scored on average higher on all three MDD severity scales as
compared to their male counterparts, illustrated by the higher P95
cut-off values. For the BDI-II the P95 values for women and men were,
respectively, 15.0 and 12.0 for the total score; 4.5 and 4.5 for the
Cognitive subscale1;10.5 and 8.0 for the Somatic-Affective subscale1;
5.0 and 2.5 for the Cognitive2 subscale; 3.0 and 2.5 for the Affective2
subscale; and 9.0 and 7.0 for the Somatic2 subscale. For the IDS-SR P95
cut-off values for women andmenwere, respectively, 23.0 and 18.0 for
the total score; 9.5 and 9.0 for the Atypical Characteristics subscale;
and 12.0 and 10.5 for the Melancholical Characteristics subscale. For
theMADRS, again, the P95 cut-off valuewas higher for women than for
men: 12.5 compared to 9.0.3.3.2. Receiver operating characteristic (ROC) curves
Cut-off points, deﬁned by equal sensitivity and speciﬁcity, were
calculated with ROC analyses (see Table 3).
The cut-off point of the BDI-II total score discriminating health
from disease was 13.5 with a sensitivity and speciﬁcity of 96%.
Therefore, 4% of the reference participants who had a total score of
13.5 or higher would be incorrectly classiﬁed as depressed, and
also 4% of the ROM patient group who had a total score of 13.5 or
lower would be incorrectly classiﬁed as non-depressed. The AUC
value (0.99), indicating the discriminating performance, showed
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between patients and non-patients. Although all subscales showed
excellent discriminative power, the best performing was the
Somatic-Affective subscale1. See Fig. 1 for the discriminative
powers of the three MDD scales.
The cut-off point of the IDS-SR total score discriminating health
versus disease was 18.5 with a sensitivity and speciﬁcity of 94%.
The AUC value was 0.98 for the total score, with the best
performing subscale being Melancholical Characteristics. The
cut-off point of the MADRS total score discriminating health
versus disease was 10.5 with a sensitivity and speciﬁcity of 95%.
The AUC value was 0.99.Table 2
Percentiles and mean values for Routine Outcome Monitoring mood disorder instrumen
ROM reference-group
P5 P25 P50 (median)
Beck Depression Inventory-II (BDI-II)* (n¼455)
Total score 0 0 2
Cognitive1 0 0 0
Somatic-Affective1 0 0 2
Cognitive2 0 0 0
Affective2 0 0 0
Somatic2 0 0 1
Inventory of Depressive Symptomatology - Self-Report* (n¼769)
Total score 0 2 5
(n¼196)
Atypical characteristics3 1 3 4
(n¼165)
Melancholic characteristicsº 1 3 4
Montgomery Åsberg Depression Rating Scale** (n¼1291)
Total score 0 0 2
ROM: Routine outcome monitoring.
* BDI-II samples and IDS-SR samples were non-overlapping.
** MADRS samples were partly overlapping with BDI-II or IDS-SR samples.
1 Steer et al., 1987; Cognitive subscale comprises items 2, 3, 5, 6, 7, 8, 9 and 14; S
and 21.
2 Beck et al., 2002; Cognitive subscale comprises items 3, 5, 6, 7, 8, 13 and 14; Affectiv
15, 16, 17, 18, 19, 20 and 21.
3 Novick et al., 2005: Atypical characteristics subscale comprises items 4, 8, 9, 10, 11
º van Reedt Dortland et al;., 2010: Melancholic characteristics subscale comprise ite
Table 3
Internal consistency and cut-off scores in the ROM reference (n¼1295) and patient (n¼
Cronbach's alph
Beck Depression Inventory-II (BDI-II),
Total score 0.93
Cognitivec 0.87
Somatic-Affectivec 0.89
Cognitived 0.86
Affectived 0.83
Somaticd 0.83
Inventory of Depressive Symptomatology-Self-Report (IDS-SR)
Total score 0.94
Atypical characteristicse 0.68
Melancholic characteristicsf 0.78
Montgomery Åsberg Depression Rating Scale (MADRS)
Total score 0.90
ROM: Routine Outcome Monitoring.
a BDI-II samples and IDS-SR samples were non-overlapping.
b MADRS samples were partly overlapping with BDI-II or IDS-SR samples.
c Steer et al. (1987); Cognitive subscale comprises items 2, 3, 5, 6, 7, 8, 9 and 14; So
20 and 21.
d Beck et al. (2002); Cognitive subscale comprises items 3, 5, 6, 7, 8, 13 and 14; Affect
11, 15, 16, 17, 18, 19, 20 and 21.
e Novick et al. (2005): Atypical characteristics subscale comprises items 4, 8, 9, 10, 1
f van Reedt Dortland et al. (2010): Melancholic characteristics subscale comprise ite4. Discussion and conclusion
We reported reference values for the generic instruments BDI-
II, IDS-SR and MADRS in two large samples from a “healthy” and
“psychiatrically ill” population. P95 values of the ROM reference
group, ROC analysis based cut-off scores and P5 values of the ROM
patient group yielded almost equal values. A sex-speciﬁc pattern in
reference values was observed, with women showing higher
values than men.
The mean BDI-II scores for the ROM reference group were
lower than the mean BDI-II scores reported by Segal et al. (2008a)
(mean¼3.8, SD¼4.7 versus mean¼8.6, SD¼7.7), suggesting thatts in the ROM reference (n¼1295) and patient (n¼4627) groups.
ROM patient-group
P75 P95 Mean±SD P5 P25 P50 (median) P75 P95 Mean ± SD
(n¼4019)
5 13 3.74±4.74 14 24 30 38 49 30.80±10.52
1 5 0.98±1.67 2 7 10 14 19 10.44±5.19
4 10 2.76±3.53 9 16 20 25 31 20.36±6.64
1 4 0.95±1.72 2 6 10 13 18 9.78±4.79
1 3 0.52±1.03 3 5 7 9 12 7.09±3.06
4 8 2.27±2.74 6 11 14 17 21 13.94±4.64
(n¼474)
9 20 6.74±6.88 18 30 38 46 58 38.05±12.07
(n¼208)
6 11 4.71±3.01 8 11 14 17 21 14.12±4.13
(n¼115)
6 10 4.62±2.31 6 8 10 12 17 10.24±3.5
(n¼4627)
4 11 2.79±3.84 11 18 23 28 36 23.44±7.75
omatic-Affective subscale comprises items 1, 4, 10, 11, 12, 13, 15, 16, 17, 18, 19, 20
e subscale comprises items 1, 2, 4, 9 and 12; Somatic subscale comprises items 10, 11,
, 15, 18, 24, 33 and 34.
ms 3, 6, 9, 10, 11, 12, 17, 20, 25, 27 and 28.
4627) groups for Routine Outcome Monitoring depressive disorder instruments.
a Number of items N ROC cut-off AUC Sensitivity/speciﬁcity
4474a
21 13.5 0.99 0.96
8 3.5 0.97 0.91/0.093
13 9.5 0.99 0.95
7 3.5 0.97 0.91/0.93
5 2.5 0.98 0.95
9 7.5 0.98 0.92/0.94
1243a
32 18.5 0.98 0.94
10 7.5 0.92 0.84
11 9.5 0.97 0.94/0.91
5918b
10 10.5 0.99 0.95
matic-Affective subscale comprises items 1, 4, 10, 11, 12, 13, 15, 16, 17, 18, 19,
ive subscale comprises items 1, 2, 4, 9 and 12; Somatic subscale comprises items 10,
1, 15, 18, 24, 33 and 34.
ms 3, 6, 9, 10, 11, 12, 17, 20, 25, 27 and 28.
Fig. 1. Distribution of the scores of Beck Depression Inventory-II (BDI-II) total scale,
the Inventory of Depressive Symptoms (self-report) (IDS-SR) total scale and the
Montgomery Äsberg Depression Rating Scale (MADRS). Three types of cut-off
points are depicted: the 75th percentile score (P75), the 95th percentile score (P95)
and the Receiver Operating Characteristics (ROC) cut-off point deﬁned by equal
sensitivity and speciﬁcity.
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from our ROM reference group, however, was slightly higher than
the mean IDS-SR scores reported by Rush et al. (1986) (mean¼6.7,
SD¼6.9 versus mean¼2.1, SD¼2.2). It should be noted however
that their skewed distributions preclude an accurate comparison
of these parametric estimates. The ROC cut-off value for the ROM
reference group was similar to the one reported later by Rush et al.
(1996) (18.5 versus 18.0). The mean MADRS score for the ROM
reference group was slightly lower than the weighted mean
MADRS score reported by Zimmerman et al. (2004a) (mean¼2.8,
SD¼3.8 versus mean¼4.0, SD¼5.8). These differences amongstudies are relatively small and of minor clinical importance, and
may be due to sociodemographic and socio-cultural differences.
The larger size of our ROM reference group has probably yielded
rather precise estimates. The high internal consistency of the BDI-
II, IDS-SR and MADRS are in accordance with previous studies (De
Beurs et al., 2009; De Beurs and Zitman, 2006; DeRogatis and
Melisaratos 1983; Gandek and Ware, Jr., 1998; Van Kampen et al.,
2008; Wardenaar et al., 2010).
The results of our study have the following clinical implica-
tions. The excellent performance of the instruments indicates that
our reference values are suitable for different purposes: (1)
diagnostics; (2) decisions about treatment termination and refer-
ral back to primary care; (3) identiﬁcation of people who may
beneﬁt from referral by primary care to specialized mental health
care. Regarding diagnostics, these cutoff values can aid in the
screening for MDD, although clinical judgment and validated
diagnostic tools (e.g., MINI (Sheehan et al., 1998; Van Vliet et al.,
2000), Composite International Diagnostic Interview (CIDI) (World
Health Organization, 1990), the Structured Clinical Interview for
Diagnostic and Statistical Manual (DSM)-III-R (SCID) (Spitzer et al.,
1988) remain the “gold standard”. Moreover, cut-off scores may be
used to classify depression severity (Beck et al., 1996a). When
making decisions about treatment termination or referral to
primary care, speciﬁcity has to be high. The 95th percentile scores
of the ROM reference group results in few false positives. For
referral from primary care to specialized mental health care, cut-
off scores with a high sensitivity are more appropriate, and we
recommend ROC-based cut-offs or 5th percentile scores from the
ROM patient group for that purpose.
It is of note that the 95th percentile of the reference group, the
5th percentile of the patient group and the ROC cut-off values
largely overlapped. They were also largely consistent with the cut-
off values used for the BDI-II, IDS-SR and MADRS to distinguish
individuals without depressive symptoms from those with mild
symptoms (being 14, 18 and 12, respectively) (Beck et al., 1996b;
Montgomery et al., 1993; Rush et al., 1996). Furthermore, women
from the ROM reference group scored on average higher on all
three MDD severity scales than males. For the BDI-II P95 values
were 15 and 12, for the IDS-SR 23 and 18, and for the MADRS 12.5
and 9, in women and men, respectively. It may be too early to
recommend gender speciﬁc reference values as more research is
needed in reference populations. Nevertheless it was striking that
reference values from non-depressed populations showed clini-
cally important differences. Most previous studies did not stratify
for gender (Rush et al., 1986; Segal et al., 2008a; Zimmerman et al.,
2004a) but the one who did (Rush et al., 1996) found no gender
differences. For the self-report BDI-II and IDS-SR higher age was
associated with higher P95 reference scores in women and men
from the ROM reference group, which was not the case for the
observer-rated MADRS. Therefore, age-speciﬁc reference values
seem redundant.
The present study has several strengths. First, the assessment
procedures for both groups were standardized and of high quality
(ascertained by training and supervision). Second, the ROM
reference group was large, clearly deﬁned and resembled the
patient group in all relevant respects (age, gender, level of
urbanization) other than those under investigation (level of
psychopathology). Furthermore, it likely represents the general
population quite well, because of the high GP registration rate in
the Netherlands. Finally, stratiﬁcation of the ROM reference group
into more homogeneous gender- and age-subgroups may have
reduced variation among subgroups leading to gender-speciﬁc
reference values to be used in clinical practice.
Limitations of the present study include the non-response in
the ROM reference group. This was substantial at 63.2%, implying
potential selection bias. Participation bias may have resulted in
Y.W.M. Schulte-van Maaren et al. / Journal of Affective Disorders 149 (2013) 342–349348slightly higher cut-off and percentile scores. Furthermore, because
the BDI-II was replaced by the IDS-SR during the study, sample
sizes of ROM patients that completed the IDS-SR and of ROM
reference subjects that completed the BDI-II varied among the
three scales. Additionally, the generalizability of this study is
limited by the nature of our ROM reference group that was
Dutch-speaking, mainly Caucasian and aged between 18 and 65.
Reference values may not automatically be applicable to other
ethnic or cultural groups, children, and the elderly. Finally, it is
important to recognize that population-based reference values
should not be applied rigidly. The choice of cut-off scores remains
arbitrary and dependent one's goal.
In conclusion, this large-scale population-based study provides
reference values and reliability coefﬁcients for the BDI-II, IDS-SR
and MADRS, improving their usability as ROM instruments for the
assessment of severity of mood disorder symptoms. Either instru-
ment can be offered to every patient with MAS disorders to make
responsible decisions about continuing, changing or terminating
therapy. Additionally, these reference values are suitable to indi-
cate patients that have recovered enough in order to be referred
back from specialized mental health care to primary care.Role of funding source
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